Literature DB >> 12413530

TNF ligands and receptors in autoimmunity: an update.

Fabienne Mackay1, Susan L Kalled.   

Abstract

Over two decades of research have increased the interest in factors from the tumor necrosis factor family. The vast majority of these factors are powerful modulators of critical immune functions and participate in pathogenic mechanisms leading to autoimmune disease. This field constantly evolves with the addition of new family members and the discovery of their function. During the past few years several additional factors from this family, such as BAFF, RANKL, TRAIL and GITRL, have emerged with novel functions that regulate both T and B cell immune tolerance and participate in tissue destruction in autoimmunity. These new findings revealed exciting innovative strategies for the treatment of autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12413530     DOI: 10.1016/s0952-7915(02)00407-7

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  30 in total

Review 1.  Keeping hopes high.

Authors:  Jocelyne Demengeot; Shohei Hori
Journal:  EMBO Rep       Date:  2003-10-24       Impact factor: 8.807

Review 2.  Modification of accessory molecule signaling.

Authors:  Mary K Crow
Journal:  Springer Semin Immunopathol       Date:  2006-05-16

3.  Fn14-TRAIL, a chimeric intercellular signal exchanger, attenuates experimental autoimmune encephalomyelitis.

Authors:  Marjaneh Razmara; Brendan Hilliard; Azadeh K Ziarani; Ramachandran Murali; Srikanth Yellayi; Mustafa Ghazanfar; Youhai H Chen; Mark L Tykocinski
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

Review 4.  TACI mutation in common variable immunodeficiency and IgA deficiency.

Authors:  Rima Rachid; Emanuela Castigli; Raif S Geha; Francisco A Bonilla
Journal:  Curr Allergy Asthma Rep       Date:  2006-09       Impact factor: 4.806

5.  Alteration of newly induced endochondral bone formation in adult mice without tumour necrosis factor receptor 1.

Authors:  I K Lukić; D Grcević; N Kovacić; V Katavić; S Ivcević; I Kalajzić; A Marusić
Journal:  Clin Exp Immunol       Date:  2005-02       Impact factor: 4.330

6.  Transduction of tumor necrosis factor-related apoptosis-inducing ligand into hematopoietic cells leads to inhibition of syngeneic tumor growth in vivo.

Authors:  Keli Song; Nordine Benhaga; Robin L Anderson; Roya Khosravi-Far
Journal:  Cancer Res       Date:  2006-06-15       Impact factor: 12.701

7.  Fas-associated protein with death domain (FADD)-independent recruitment of c-FLIPL to death receptor 5.

Authors:  Tai-Guang Jin; Alexei Kurakin; Nordine Benhaga; Karon Abe; Mehrdad Mohseni; Ferry Sandra; Keli Song; Brian K Kay; Roya Khosravi-Far
Journal:  J Biol Chem       Date:  2004-10-14       Impact factor: 5.157

8.  Epigenetics in the Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.

Authors:  Angela C Cheung; Nicholas F LaRusso; Gregory J Gores; Konstantinos N Lazaridis
Journal:  Semin Liver Dis       Date:  2017-05-31       Impact factor: 6.115

Review 9.  Design of vaccine adjuvants incorporating TNF superfamily ligands and TNF superfamily molecular mimics.

Authors:  Sachin Gupta; James M Termini; Saravana Kanagavelu; Geoffrey W Stone
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

10.  Glucocorticoid-induced tumor necrosis factor receptor negatively regulates activation of human primary natural killer (NK) cells by blocking proliferative signals and increasing NK cell apoptosis.

Authors:  Baoying Liu; Zhuqing Li; Sankaranarayana P Mahesh; Seth Pantanelli; Frank S Hwang; Willie O Siu; Robert B Nussenblatt
Journal:  J Biol Chem       Date:  2008-01-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.